Weather threats to drug production facilities examined in study
A JAMA study published Aug. 20 found that nearly 63% of all U.S. drug production facilities from 2019 through 2024 were in counties where a weather disaster declaration was declared. About 34% of facilities were in such areas annually during the study period. Researchers said the findings demonstrate an urgent need for supply chain transparency, strategic allocation of production, and disaster risk management strategies to prevent future health care disruptions in the U.S.
Related News Articles
Headline
The Centers for Medicare & Medicaid Services’ six-month moratorium on the enrollment of new durable medical equipment, prosthetics, orthotics and supply…
Headline
The Federal Office of Rural Health Policy’s Rural Health Redesign Center will host a webinar on Sept. 24 at 2 p.m. ET, where hospital CEOs will discuss the…
Headline
The AHA’s Association for the Health Care Environment will host a webinar Sept. 8 at 2 p.m. ET that will discuss strategies environmental services leaders can…
Headline
There have been 15,716 confirmed cases of cyclosporiasis across 47 states, Washington, D.C., and Puerto Rico since May 1, the Centers for Disease Control and…
Headline
The AHA will make a donation to the Indiana Hospital Association in support of hospital personnel impacted by the recent flooding in Indiana caused by severe…
Headline
The Centers for Disease Control and Prevention yesterday announced that the ongoing cyclosporiasis outbreak linked to iceberg lettuce has expanded to 15 states…